Association between timing of angiotensin II administration and outcomes in vasoplegia after cardiac surgery
Morbidity and mortality rates are high in patients given angiotensin II for vasoplegia. Initiating this medication intraoperatively may improve outcomes, underscoring the importance of early intervention for patients at risk for vasoplegia after CPB.
Authors
- Joseph Stapleton Coselli (ORCID: https://orcid.org/0000-0003-2176-5988)
- Michael Tyler Guinn (ORCID: https://orcid.org/0000-0002-7891-8765)
- Todd K. Rosengart
- Travis J Miles (ORCID: https://orcid.org/0009-0008-2687-2380)
- Orlando R. Suero
- Ravi K. Ghanta (ORCID: https://orcid.org/0000-0003-3299-2668)
- Marc R. Moon (ORCID: https://orcid.org/0000-0002-4473-6867)
- Subhasis Chatterjee (ORCID: https://orcid.org/0000-0002-0803-8826)
Institutions
- Baylor College of Medicine (US)
Publication Details
- Journal
- JTCVS Open
- Published
- 2025-04-25
- DOI
- https://doi.org/10.1016/j.xjon.2025.04.014
- Citations
- 3
- Primary Topic
- Cardiac, Anesthesia and Surgical Outcomes
- Type
- article
- Field-Weighted Citation Impact
- 4.16